In-Trial Interviews
CLINIGMA® is a market-leading specialist for in-trial interviews. We know patients bring exceptional insights to inform drug development. Our dedicated team and seamless ICH-GCP compliant interview solutions produce the evidence you need to strengthen your regulatory submission.
Patient experience data made easy
CLINIGMA®’s systematic approach and attention to detail make in-trial interview projects easy and secure for clients, clinical sites, and patients. By seamlessly integrating patient interviews into clinical trials, our services ultimately put patients' voices at the heart of drug development and regulatory decision-making.
Why choose CLINIGMA® for in-trial interviews?
Scientific expertise
Our science team is comprised of experienced industry professionals with diverse expertise in drug development, clinical trials, and qualitative research methods.
The CLINIGMA® Portal
Our proprietary platform makes every aspect of the interview process easy, secure, and ICH-GCP compliant, optimizing data collection, patient privacy, and safety.
Project management expertise
Our team of international experts effortlessly manage every step of the process to deliver timely patient insights.
Highly skilled interviewers
Our team of interviewers and translators delivers high quality patient experience data. Each interviewer is a highly skilled qualitative researcher, trained in ICH-GCP and project-specific requirements to ensure patient safety, ethics, and in-depth data collection.
Global regulatory knowledge
Our approach ensures alignment with both global and local regulatory frameworks, applying best practices to safeguard patient safety, ensure data integrity, and promote transparency.
Trusted partner
By choosing to work with us, you gain not just a service provider, but a trusted partner who is passionate about advancing healthcare and improving patient outcomes.
Interview
countries globally
Interview
languages available
Qualitative
researchers worldwide
Focused on
capturing patient feedback
Why patient voices matter
Listen to our chief scientific officer, Anna Ryden (PhD), describe the value of qualitative interviews to provide an in-depth understanding of the patient experience in drug development.
Client testimonials
I think you guys are amazing. We need more vendors like this! We are very, very satisfied with CLINIGMA®. If I had to do an interview sub-study again, I would definitely push to do it with CLINIGMA®.
Discover moreOur commitment to listen to patients
CLINIGMA® was built on the belief that drug development and regulatory decision-making must be more responsive to what patients actually experience and value. That’s why Jens Harald Kongsø founded CLINIGMA®.
Watch the video to hear more about our story and commitment to patient-focused drug development.
We deliver high-quality
patient interviews
We are expert partners in ICH-GCP compliant in-trial interviews for patient-focused drug development. Get in touch with one of our experts.
© Copyright 2025
CLINIGMA® All rights reserved